Antimicrobial combinations against Helicobacter pylori including benzoxadiazol-based flavodoxin inhibitors: in vitro characterization.

Published in: Microbiology spectrum (2023)

infection, potentially reducing the development of resistance and shortening the treatment duration.

Keyphrases